Search bioRxivSearch

bioRxiv · 10.1101/108993

Broadband spectral responses in visual cortex revealed by a new MEG denoising algorithm

Abstract

Currently, non-invasive methods for studying the human brain do not reliably measure spike-rate-dependent signals, independent of other responses such as hemodynamic coupling (fMRI) and subthreshold neuronal synchrony (oscillations and event-related potentials). In contrast, invasive methods - animal microelectrode recordings and human electrocorticography (ECoG) - have recently measured broadband power elevation in field potentials (~50-200Hz) as a proxy for the locally averaged spike rates. Here, we sought to detect and quantify stimulus-related broadband responses using magnetoencephalography (MEG) in individual subjects. Because extracranial measurements like MEG have multiple global noise sources and a relatively low signal-to-noise ratio, we developed an automated denoising technique, adapted from (Kay et al., 2013), that helps reveal the broadband signal of interest. Subjects viewed 12-Hz contrast-reversing patterns in the left, right, or bilateral visual field. Sensor time series were separated into an evoked component (12-Hz amplitude) and a broadband component (60-150Hz, excluding stimulus harmonics). In all subjects, denoised broadband responses were reliably measured in sensors over occipital cortex. The spatial pattern of the broadband measure depended on the stimulus, with greater broadband power in sensors contralateral to the stimulus. Because we obtain reliable broadband estimates with relatively short experiments (~20 minutes), with a sufficient signal-to-noise-ratio to distinguish responses to different stimuli, we conclude that MEG broadband signals, denoised with our method, offer a practical, non-invasive means for characterizing spike-rate-dependent neural activity for a wide range of scientific questions about human brain function.\n\nSignificance StatementNeuronal activity causes perturbations in nearby electrical fields. These perturbations can be measured non-invasively in the living human brain using EEG and MEG. These techniques have emphasized two kinds of measurements: oscillations and event-related responses. A third type of signal, a stimulus-related increase in power spanning a wide range of frequencies ( broadband), is routinely measured in invasive recordings, but not with MEG and EEG. This broadband response is of great interest because unlike oscillations and event-related responses, it is correlated with neuronal spike rates. Here we report quantitative, spatially specific measurements of broadband fields in individual human subjects using MEG. These results demonstrate that a spike-rate-dependent measure of brain activity can be obtained non-invasively from the living human brain.

Source connections

Explore related subjects

Keep this discovery

BibTeXRIS

Kupers, E. R., Wang, H. X., Amano, K., Kay, K. N., Heeger, D. J., Winawer, J.. 2017-02-15. Broadband spectral responses in visual cortex revealed by a new MEG denoising algorithm. https://doi.org/10.1101/108993

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience